Upgrade to SI Premium - Free Trial

MKM Says Alkermes (ALKS) Quarter Positive, Notes Revenue Miss Timing-Related

November 2, 2012 11:14 AM
MKM Partners reiterated a Buy rating on Alkermes (NASDAQ: ALKS) and raised its price target to $23.00 (from $22.00).


(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles